Nkọwa ngwa ngwa
Antigen ebumnuche: protein Nucleocapsid, ngbanwe nje adịghị emetụta ya
Akụrụngwa dị oke mma: mgbochi mmadụ, nkọwapụta dị elu
Ngwakọta ọla edo sitere na German, Merck (Top 1), mmetụta dị elu
Nkwakọ ngwaahịa & nnyefe
| Nkọwa ngwugwu:Ngwungwu mbupụ ọkọlọtọ Nkọwa nnyefe: n'ime 7-10 ụbọchị ọrụ mgbe nnata nke ugwo |
Nkọwapụta
Ngwa nyocha Lepu COVID-19 antigen AMPRP78 maka ọrịre
Ngwa ule Lepu SARS-CoV-2 antigen AMPRP78 bụ immunoassay ngwa ngwa n'akụkụ mpụta iji chọpụta nke ọma antigens kpọmkwem na AMPRP78 na traktị iku ume mmadụ, nyere aka nyocha ma ọ bụ chọpụta nnukwu ọrịa coronavirus ọhụrụ.
Nhọrọ dị mma nke ihe
1.Target antigen: Nucleocapsid protein, ọ bụghị emetụta nje mutation.
2.Excellent raw material: Humanized antibody, high specificity.
3.Gold nanoparticles si German, Merck (Top 1), mmetụta dị elu.
4.NC akpụkpọ anụ si German, Sartorius (Top 1), elu mma.
5.Sterile swab kwadoro site n'ahụ mara ọkwa.
Ihe nyocha Lepu COVID-19 antigen AMPRP78 maka ọrịre arụmọrụ na ojiji dị mma
1.Multi-specification kits: 1, 5, 10, 25 T / Kit nwere ike ịnye.
2.The tupu ngwugwu diluent nwere ike jikọta ya na swab samples ma jiri ya mee ihe, nke na-adịghị mkpa ka ekewapụ ọzọ.Enwere ike iji enyi na enyi karịa, enwere ike iji obere mkpọ reagent mee ka usoro ahụ dị mkpụmkpụ ma belata mmetọ mmadụ mere.
Ngwa ule Lepu COVID-19 antigen AMPRP78 maka ọrịre arụmọrụ ụlọ ọgwụ asọmpi
1.Nkwekọrịta pasent nke ọma (uche): 95.03% (95% CI: 90.77% ~ 97.70%)
2.Nkwekọrịta pasent na-adịghị mma (kpọmkwem): 99.02% (95% CI: 96.52-99.88%)
3.Overall percent nkwekọrịta (nkenke): 97.15% (95% CI: 94.96% ~ 98.57%)
Obodo ndebanye aha: Germany, France, Italy, Peru, Serbia na ndị ọzọ.
